Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight

Cancer Causes and Control

Volumn 23, Issue 4, 2012, Pages 635-645

  Hoyo, Cathrine ^a,b   Fortner, Kimberly ^b   Murtha, Amy P ^b   Schildkraut, Joellen M ^a   Soubry, Adelheid ^a   Demark Wahnefried, Wendy ^c   Jirtle, Randy L ^a   Kurtzberg, Joanne ^a   Forman, Michele R ^c   Overcash, Francine ^a   Huang, Zhiqing ^a,b   Murphy, Susan K ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA methylation; ELISA; Epidemiology; Epigenetics; H19; IGF2

Indexed keywords

SOMATOMEDIN B;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DIFFERENTIALLY METHYLATED REGION; DNA METHYLATION; DNA STRUCTURE; FEMALE; GENE; GENOME IMPRINTING; HIGH BIRTH WEIGHT; HUMAN; IGF2 GENE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD;

BIRTH WEIGHT; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR II; MALE;

EID: 84862493910     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9932-y     Document Type: Article

References (52)

1. Bateson P, Barker D, Clutton-Brock T et al (2004) Developmental plasticity and human health. Nature 430:419-421 (Pubitemid 38987896)
2. Cui H, Cruz-Correa M, Giardiello FM et al (2003) Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753-1755 New York, NY (Pubitemid 36337205)
3. Nowakowska-Zajdel E, Mazurek U, Ziolko E et al (2011) Analysis of expression profile of gene encoding proteins of signal cascades activated by insulin-like growth factors in colorectal cancer. Int J Immunopathol Pharmacol 24:781-787
4. Murphy SK, Huang Z, Wen Y et al (2006) Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res 4:283-292
5. Jarrard DF, Bussemakers MJ, Bova GS, Isaacs WB (1995) Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Clin Cancer Res 1:1471-1478 (Pubitemid 26028082)
6. Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF (2011) Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer. Prostate 71:1621-1630
7. Zuo QS, Yan R, Feng DX et al (2011) Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Mol Carcinog 50:390-396
8. Xu W, Fan H, He X, Zhang J, Xie W (2006) LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. J Exp Clin Cancer Res 25:543-547 (Pubitemid 46166769)
9. Wu AH, McKean-Cowdin R, Tseng CC (2011) Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans. Breast Cancer Res Treat 130:917-925
10. Forman MR, Cantwell MM, Ronckers C, Zhang Y (2005) Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest 23:609-624 (Pubitemid 43286663)
11. Bagchi S (2005) Intrauterine growth linked to aggressive prostate cancer. Lancet Oncol 6:70
12. Eriksson M, Wedel H, Wallander MA et al (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67:1247-1254 (Pubitemid 47221892)
13. Nilsen TI, Romundstad PR, Troisi R, Vatten LJ (2005) Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int J Cancer 113:1002-1004 (Pubitemid 40096881)
14. Akre O, Forssell L, Kaijser M et al (2006) Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study. Cancer Epidemiol Biomarkers Prev 15:867-871 (Pubitemid 43823510)
15. Kaijser M, Akre O, Cnattingius S, Ekbom A (2005) Preterm birth, low birth weight, and risk for esophageal adenocarcinoma. Gastroenterology 128:607-609 (Pubitemid 40585362)
16. Strathdee G, Sim A, Brown R (2004) Control of gene expression by CpG island methylation in normal cells. Biochem Soc Trans 32:913-915 (Pubitemid 39655502)
17. Waterland RA, Kellermayer R, Laritsky E et al (2010) Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet 6:e1001252
18. Woodfine K, Huddleston JE, Murrell A (2011) Quantitative analysis of DNA methylation at all human imprinted regions reveals preservation of epigenetic stability in adult somatic tissue. Epigenetics Chromatin 4:1
19. Murphy SK, Jirtle RL (2003) Imprinting evolution and the price of silence. Bioassays 25:577-588 (Pubitemid 36702326)
20. Murrell A, Ito Y, Verde G et al (2008) Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. PLoS ONE 3:e1849
21. Cui H, Niemitz EL, Ravenel JD et al (2001) Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res 61:4947-4950 (Pubitemid 32681515)
22. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62:6442-6446 (Pubitemid 35364103)
23. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A (2001) Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A 98:591-596 (Pubitemid 32105087)
24. Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE (1999) Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene 18:7527-7534 (Pubitemid 30035053)
25. Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA (2001) Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 10:2619-2626 (Pubitemid 33133402)
26. Heijmans BT, Tobi EW, Stein AD et al (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105:17046-17049
27. Hoyo C, Murphy SK, Jirtle RL (2009) Imprint regulatory elements as epigenetic biosensors of exposure in epidemiological studies. J Epidemiol Community Health 63:683-684
28. Heijmans BT, Tobi EW, Lumey LH, Slagboom PE (2009) The epigenome: archive of the prenatal environment. Epigenetics 4:526-531
29. Hoyo C, Murtha AP, Schildkraut JM et al (2011) Folic acid supplementation before and during pregnancy in the newborn epigenetics study (NEST). BMC Public Health 11:46
30. Hoyo C, Murtha AP, Schildkraut JM et al (2011) Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy. Epigenetics 6:928-936
31. Huang Z, Wen Y, Shandilya R, Marks JR, Berchuck A, Murphy SK (2006) High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucleic Acids Res 34:555-563 (Pubitemid 43240243)
32. Umbers AJ, Boeuf P, Clapham C et al (2011) Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis 203:561-569
33. Schlinzig T, Johansson S, Gunnar A, Ekstrom TJ, Norman M (2009) Epigenetic modulation at birth - altered DNA-methylation in white blood cells after caesarean section. Acta Paediatr 98:1096-1099
34. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D et al (2009) Periconceptional maternal folic acid use of 400 microg per day Is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 4:e7845
35. Talens RP, Boomsma DI, Tobi EW et al (2010) Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J 24:3135-3144
36. Edwards CA, Rens W, Clarke O et al (2007) The evolution of imprinting: chromosomal mapping of orthologues of mammalian imprinted domains in monotreme and marsupial mammals. BMC Evol Biol 7:157
37. Varrault A, Gueydan C, Delalbre A et al (2006) Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell 11:711-722 (Pubitemid 44752557)
38. Cruz-Correa M, Zhao R, Oviedo M et al. (2009) Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Epigenetics 4:114-118
39. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev 8:253-262 (Pubitemid 46439287)
40. Feinberg AP (2007) An epigenetic approach to cancer etiology. Cancer J 13:70-74 (SudburyMass)
41. Cruz-Correa M, Cui H, Giardiello FM et al (2004) Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 126:964-970 (Pubitemid 38451167)
42. Dammann RH, Kirsch S, Schagdarsurengin U et al (2010) Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma. Int J Oncol 36:171-179
43. Yang R, Wang Y, Zhu X, Gao X (2009) Study on genomic imprinting of IGF2 in breast cancer. Wei sheng yan jiu. J Hyg Res 38:423-425
44. Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG (2009) Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues. Carcinogenesis 30:2117-2122
45. Paradowska A, Fenic I, Konrad L et al (2009) Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia. Int J Oncol 35:87-96
46. Johnsen SP, Sorensen HT, Thomsen JL et al (2004) Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults. Eur J Epidemiol 19:41-47 (Pubitemid 38250052)
47. Fowke JH, Matthews CE, Yu H et al (2010) Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocr Relat Cancer 17:51-60
48. Gronbaek H, Flyvbjerg A, Mellemkjaer L et al (2004) Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:1759-1764
49. Shetty PJ, Movva S, Pasupuleti N et al (2011) Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer. J Cancer Res Clin Oncol 137:339-345
50. Murphy SK, Wylie AA, Coveler KJ et al (2003) Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat 22:92-97
51. Murrell A, Ito Y, Verde G et al (2008) Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. PLoS ONE 3:e1849
52. Turan N, Katari S, Gerson LF et al (2010) Inter- and intra-individual variation in allele-specific DNA methylation and gene expression in children conceived using assisted reproductive technology. PLoS Genet 6:e1001033